Digestive Health

The clinical practice update incorporates emerging evidence and available guidance for patients with IBD.

The study was the first to examine proton pump inhibitors use in breast cancer survivors.

Tofacitinib, currently used to treat rheumatoid arthritis and ulcerative colitis, has a correcting effect on defects that occur in inflammation.

After some lots of ranitidine were found to contain small amounts of N-nitrosodimethylamine (NDMA), Novartis's Sandoz unit has announced that they are halting distribution of ranitidine (Zantac) products until the contamination concerns are resolved.

Officials from the FDA have announced an approved package size and package type limit for over-the-counter (OTC) brand-name tablet and capsule forms of loperamide.

An over-the-counter and prescription drug, ranitidine is an H2 (histamine-2) blocker that decreases the amount of acid created by the stomach.

Health care professionals can play an important role in managing patients with diarrhea by recommending OTC products for initial treatment.

This edition features 4 case studies with information including adverse effects of fiber consumption, using ginger for morning sickness, help for dysmenorrhea, and products for heartburn.

Pharmacists are instrumental in guiding patients on the appropriate and safe use of products for gastrointestinal discomfort.

Just 22% of those who suffer seek help from a health care provider, newer agents show promise.

Diet and lifestyle changes are key components of treating gastroesophageal reflux disease.

Pharmacists can, and should, play an important role in counseling patients before they travel anywhere about what to do in the event of a GI illness while vacationing.

Travel health services involves a lot more than vaccinations, said Sheri Stensland, PharmD, in a session at McKesson ideaShare.

Parvus Therapeutics and Genentech have entered into a worldwide collaboration and licensing agreement for the development, manufacturing, and commercialization of treatments for inflammatory bowel disease, autoimmune liver diseases, and celiac disease using nanomedicines (Navacim) developed by Parvus.

Rifamycin's effectiveness was shown in a randomized, placebo-controlled clinical trial during which the drug significantly reduced symptoms of travelers’ diarrhea in adults afflicted with the condition in Guatemala and Mexico.

Patients have probably heard about probiotics and their role in maintaining digestive health, but they may be unaware of how to use them.

Pharmacy shelves are lined with a plethora of probiotic supplements, and the selection may be overwhelming for some consumers.

Proton pump inhibitors may lead to an imbalance of Enterococcus bacteria and increase the risk of liver injury.

Children born to mothers who took heartburn medication were more likely to visit the physician for asthma symptoms.

Proton pump inhibitors combined with a certain chemotherapy drug may lower the possibility for cancer patients to recover and survive.

Proton pump inhibitors and histamine receptor-2 blockers have damaging effects on the kidneys.

Acid reflux can lead to Barrett’s esophagus, which increases the chance of developing esophageal cancer.

Recent study on healing rates of reflux esophagitis patients suggests that some refractory patients may heal with extended acid suppression treatment.